Displaying drugs 4551 - 4575 of 5959 in total
Asafoetida
Experimental
MAX-40279
MAX-40279 is under investigation in clinical trial NCT03412292 (MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)).
Investigational
2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate
Experimental
Indole-3-Propanol Phosphate
Experimental
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
Experimental
Hydrogen
Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).
Investigational
FR236913
Experimental
FR230513
Experimental
KW-2450 free base
Experimental
TAK-418 free base
Investigational
TH-9402 free base
Investigational
3D-185 free base
Investigational
BMX-001 free base
Investigational
TAK-075 Free base
Investigational
Adrenomedullin
Adrenomedullin is under investigation in clinical trial NCT06072118 (Adrenomedullin for CADASIL).
Investigational
Matched Categories: … Respiratory System Agents …
CLX-0921
CLX-0921 is investigated for use/treatment in diabetes mellitus type 2. CLX-0921 is a solid. CLX-0921 has a spectrum of activity that differs from commercially available thiazolidinediones. This substance targets the protein peroxisome proliferator-activated receptor gamma. It is a pharmacologically active antihyperglycemic agent that acts by increasing peripheral tissue sensitivity to...
Investigational
Matched Description: … This substance targets the protein peroxisome proliferator-activated receptor gamma. …
(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide
(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide is a solid. This compound belongs to the oxepanes. These are compounds containing an oxepane ring, which is an a seven-member saturated aliphatic heterocycle with one oxygen and six carbon atoms. This drug targets the protein beta-glucosidase A.
Experimental
Matched Description: … This drug targets the protein beta-glucosidase A. …
BB-301
BB-301 is a modified AAV serotype 9 (AAV9) capsid expressing a unique, single bifunctional construct promoting co-expression of both codon-optimized Poly-A Binding Protein Nuclear-1 (PABPN1) and two small inhibitory RNAs (siRNAs) against mutant PABPN1. Developed by Benitec Biopharma, BB-301 is being investigated for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD).
Investigational
Matched Description: … unique, single bifunctional construct promoting co-expression of both codon-optimized Poly-A Binding Protein …
Furoyl-Leucine
Experimental
Fosdagrocorat
Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.
Investigational
Firtecan pegol
Firtecan pegol is under investigation in clinical trial NCT01036113 (A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer).
Investigational
AAV1-FS344
AAV1-FS344 is an investigational gene therapy developed by Milo Biotechnology to deliver follistatin, a potent myostatin inhibitor. It is being investigated for the treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and inclusion body myositis.[L46742, L46747, L46752]
Investigational
Fosciclopirox
Investigational
Sambucus nigra flowering top
Experimental
MVA-mBN226B
Investigational
Displaying drugs 4551 - 4575 of 5959 in total